AIIMS Delhi, Blockchain For Impact to advance biomedical innovation in India

AIIMS and BFI Unite to Combat Recurrent UTIs

AIIMS Delhi has partnered with Blockchain For Impact (BFI) to enhance biomedical research and innovation in India. The collaboration will focus on identifying potential markers for recurrent urinary tract infections (rUTI). Dec 20, 2024
1st malaria vaccine shows promise against rising cases: Report

Promising results for world's first Malaria vaccine RH5.1/Matrix-M: Report

The global fight against malaria has taken a significant leap forward with the development of the first blood-stage malaria vaccine, RH5.1/Matrix-M. According to a report released by GlobalData, a leading data and analytics company, the vaccine has shown promising results and could play a crucial role in the evolving strategy against malaria. Dec 19, 2024
MEDICINE

India Becomes Third Largest Pharma Market Globally

India's pharmaceutical industry, valued at $50 billion, is the third largest globally by volume, with a strong global presence and diversified product base. The Department of Pharmaceuticals has established seven National Institutes of Pharmaceutical Education and Research (NIPERs) for high-end research and education. Dec 19, 2024
Delhi-NCR on ventilator as air quality turns toxic

Delhi-NCR Battles Hazardous Air Quality Amid Winter Chill

Delhi along with its neighboring regions, is currently grappling with a severe air pollution crisis. The Central Pollution Control Board (CPCB) has reported that the air quality in Delhi has plummeted to hazardous levels, with the average Air Quality Index (AQI) recorded at 448 at 7 A.M. on Thursday. Dec 19, 2024